OncoSec Medical Incorporated ("OncoSec") (NASDAQ:ONCS), a company developing DNA-based cancer immunotherapies, will present emerging data from its novel, multi-gene expression platform termed...

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced seven presentations of updated clinical and preclinical data at the Society for Immunotherapy...

Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, will present several...

Eidos Therapeutics, a subsidiary of BridgeBio Pharma, today announced two upcoming oral presentations regarding AG10, its therapeutic candidate for transthyretin amyloidosis, at the American Heart...